Radioactive microspheres made of nanoporous glass for radiation therapy
Microspheres made of solid glass are used in radiation therapy, wherein the radiotherapeutic radionuclide must be generated in the glass by neutron activation. Microspheres of this type have a high radioactive load, are relatively heavy and contain additional non-therapeutic radionuclides. Additionally, radioactive microspheres made of plastic are used, which can be loaded with radionuclides by chemical means. These microspheres have a lower loading capacity, no additional radionuclides, and are lighter. The therapeutic radionuclide in both cases is Y-90. Microspheres made of nanoporous glass contain the therapeutic radionuclide, have a high loading capacity, require no neutron activation, can be parallel charged with multiple therapeutic and with diagnostic radionuclides, and are very light. It is possible to produce them in a radiochemical laboratory. Microspheres of this type can also be used diagnostically in preparation for therapy. For this purpose, they can be provided in a therapeutically or diagnostically specified quantity and radioactivity.
1. A process for making radioactive glass microspheres for radiation therapy, wherein each glass microsphere has nanopores and each nanopore has a surface, the process comprising:
a. loading the nanopores of the nanoporous glass microspheres with a loading solution comprising a radionuclide in a first acid;
b. evaporating the loading solution until the radionuclide precipitates onto the surface of the nanopores in the microspheres;
c. thermally treating the microspheres so that precipitated radionuclide salt is converted into a low-solubility or insoluble form and is affixed to the surface of the nanopores; and
d. applying a second acid to the microspheres after thermally treating them, where the second acid is one or more of hydrofluoric acid, oxalic acid, sulphuric acid, sulphurous acid, or phosphoric acid.
2. The process of claim 1 further comprising evaporating the second acid from the microspheres.
3. The process of claim 2 wherein the evaporation of the second acid is accomplished by vacuum.
4. A process for making radioactive glass microspheres for radiation therapy, wherein each glass microsphere has nanopores and each nanopore has a surface, the process comprising:
a. loading the nanopores of the nanoporous glass microspheres with a loading solution comprising a radionuclide in a first acid wherein the radionuclide is a nitrate and the first acid is nitric acid;
b. evaporating the loading solution until the radionuclide precipitates onto the surface of the nanopores in the microspheres; and
c. thermally treating the microspheres so that precipitated radionuclide salt is converted into a low-solubility or insoluble form and is affixed to the surface of the nanopores.
5. A process for making radioactive glass microspheres for radiation therapy, wherein each glass microsphere has nanopores and each nanopore has a surface, the process comprising:
a. loading the nanopores of the nanoporous glass microspheres with a loading solution comprising a radionuclide in a first acid wherein the radionuclide is selected from Y-90 and In-111;
b. evaporating the loading solution until the radionuclide precipitates onto the surface of the nanopores in the microspheres;
c. thermally treating the microspheres so that precipitated radionuclide salt is converted into a low-solubility or insoluble form and is affixed to the surface of the nanopores.
6. A process for making radioactive glass microspheres for radiation therapy, wherein each glass microsphere has nanopores and each nanopore has a surface, the process comprising:
a. saturating the nanopores of the nanoporous glass microspheres with a loading solution comprising a radionuclide in an acid, until the nanopores are filled with the loading solution wherein the radionuclide is selected from Y-90 and In-111; and
b. thermally treating the microspheres until the radionuclide precipitates onto the surface of the nanopores in the microspheres and the precipitated radionuclide salt is converted into a low-solubility or insoluble form and is affixed to the surface of the nanopores.